Mir-126 Is Downregulated in Cystic Fibrosis Airway Epithelial Cells and Regulates TOM1 Expression

Total Page:16

File Type:pdf, Size:1020Kb

Mir-126 Is Downregulated in Cystic Fibrosis Airway Epithelial Cells and Regulates TOM1 Expression miR-126 Is Downregulated in Cystic Fibrosis Airway Epithelial Cells and Regulates TOM1 Expression This information is current as Irene K. Oglesby, Isabella M. Bray, Sanjay H. Chotirmall, of September 27, 2021. Raymond L. Stallings, Shane J. O'Neill, Noel G. McElvaney and Catherine M. Greene J Immunol published online 18 January 2010 http://www.jimmunol.org/content/early/2010/01/18/jimmun ol.0902669 Downloaded from Supplementary http://www.jimmunol.org/content/suppl/2010/01/13/jimmunol.090266 Material 9.DC1 http://www.jimmunol.org/ Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication by guest on September 27, 2021 *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. Published January 18, 2010, doi:10.4049/jimmunol.0902669 The Journal of Immunology miR-126 Is Downregulated in Cystic Fibrosis Airway Epithelial Cells and Regulates TOM1 Expression Irene K. Oglesby,* Isabella M. Bray,† Sanjay H. Chotirmall,* Raymond L. Stallings,† Shane J. O’Neill,* Noel G. McElvaney,*,1 and Catherine M. Greene*,1 Cystic fibrosis (CF) is one of the most common lethal genetic diseases in which the role of microRNAs has yet to be explored. Predicted to be regulated by miR-126, TOM1 (target of Myb1) has been shown to interact with Toll-interacting protein, forming a complex to regulate endosomal trafficking of ubiquitinated proteins. TOM1 has also been proposed as a negative regulator of IL- 1b and TNF-a–induced signaling pathways. MiR-126 is highly expressed in the lung, and we now show for the first time differential expression of miR-126 in CF versus non-CF airway epithelial cells both in vitro and in vivo. MiR-126 downregulation in CF bronchial epithelial cells correlated with a significant upregulation of TOM1 mRNA, both in vitro and in vivo when compared with their non-CF counterparts. Introduction of synthetic pre–miR-126 inhibited luciferase activity in a reporter Downloaded from system containing the full length 39-untranslated region of TOM1 and resulted in decreased TOM1 protein production in CF bronchial epithelial cells. Following stimulation with LPS or IL-1b, overexpression of TOM1 was found to downregulate NF-kB luciferase activity. Conversely, TOM1 knockdown resulted in a significant increase in NF-kB regulated IL-8 secretion. These data show that miR-126 is differentially regulated in CF versus non-CF airway epithelial cells and that TOM1 is a miR-126 target that may have an important role in regulating innate immune responses in the CF lung. To our knowledge, this study is the first to report of a role for TOM1 in the TLR2/4 signaling pathways and the first to describe microRNA involvement in CF. The Journal http://www.jimmunol.org/ of Immunology, 2010, 184: 000–000. ystic fibrosis (CF) is an inherited disorder characterized by flammatory cytokines (2). Therefore, TLRs and their signaling chronic airway inflammation. Bronchial epithelial cells intermediates represent potential therapeutic targets for CF. Despite C contribute significantly to the pulmonary inflammation significant advances in treatment regimes, CF remains a condition evident in CF. LPS and IL-1b, which bind to TLR4 and the IL-1RI for which there is no effective cure. Therefore, investigating the respectively, also play a pivotal role in this process. These agonists expression and function of microRNAs (miRNAs) in CF will shed can activate the innate immune response culminating in proin- light on previously unidentified regulatory mechanisms controlling flammatory gene expression leading to neutrophil-dominated air- changes in gene expression and direct the development of future by guest on September 27, 2021 way inflammation and tissue damage in the CF lung. IL-1RI and therapeutic strategies for this debilitating and fatal disorder. TLRs are present on a variety of cell types, including both immune Expanding interest in miRNAs over the past decade has uncovered cells and epithelial cells within the lung. In the context of CF, airway their importance in several biological processes and has identified epithelial cells have been shown to promote proinflammatory gene diseasestateswithalteredmiRNAexpressionpatterns.miRNAsare20– transcription following stimulation with their cognate agonists (1, 25 nucleotides long and negatively regulate gene expression at a post- 2). For example, in airway epithelial cells of non-CF and CF origin transcriptional level. Within each miRNA there exists a 2–8-nucleotide triacylated lipopeptide, LPS or unmethylated CpG DNA can induce seed region thought to be critical for target selection (3). Mature IL-6, IL-8, and TNF-a production via TLRs 2, 4, and 9 (1). Simi- miRNAs use this seed region to bind selectively to miRNA recognition larly, IL-1b can upregulate production of a plethora of proin- elements (MREs) within the 39UTR of target mRNAs. Different target genes may have several MREs and therefore be regulated by numerous miRNAs. The number of and distance between MREs are considered *Respiratory Research Division, Department of Medicine, Royal College of Sur- important for the biological activity of miRNAs. Relatively few † geons in Ireland, Beaumont Hospital; and Cancer Genetics Group, Royal College miRNAs have been studied in detail, and hence the biological rele- of Surgeons in Ireland, Dublin, Ireland vance of the majority remains to be uncovered. Expression levels vary 1N.G.M. and C.M.G. share joint senior authorship. greatly among tissues, and it is believed that dysregulation of miRNA Received for publication August 13, 2009. Accepted for publication December 3, 2009. can contribute to pathologic disease (4). Therefore, we considered it plausible to investigate whether unique miRNA expression profiles This work was supported by the Children’s Medical & Research Foundation. exist in CF, particularly in CF bronchial epithelial cells, and explore Address correspondence and reprint requests to Dr. Catherine M. Greene, Respiratory Research Division, Department of Medicine, Royal College of Surgeons in Ireland, their effects on influencing signaling pathways. Education and Research Centre, Beaumont Hospital, Dublin 9, Ireland. E-mail We performed expression profiling comparing miRNA expression address: [email protected] in CF and non-CF bronchial brushings. Based on these studies, we The online version of this article contains supplemental material. selected miR-126 for further investigation, given that its expression is Abbreviations used in this paper: Cf, Canis familiaris; CF, cystic fibrosis; CFTR, CF known to be highest invascularized tissues such as the lung, heart, and transmembrane conductance regulator; Ct, cycle threshold; ER, endoplasmic reticu- lum; Hs, Homo sapiens; miRNA, microRNA; Mm, Mus musculus; MRE, microRNA kidney (5–7), and as it has been shown to be present in bronchial recognition element; NTC, no-template control; qRT-PCR, quantitative real-time epithelium (8). miR-126 is 21 nucleotides in length, located on PCR; Rn, Rattus norvicus; Scr, scrambled control; siRNA, small interfering RNA; chromosome 9q34.3 and is contained within intron 5 of its host gene Tollip, Toll-interacting protein. epidermal growth factor like-7 (6, 9). In recent studies, miR-126 has Copyright Ó 2010 by The American Association of Immunologists, Inc. 0022-1767/10/$16.00 been shown to have functional roles in angiogenesis (10, 11), to be www.jimmunol.org/cgi/doi/10.4049/jimmunol.0902669 2 miR-126 REGULATION OF TOM1 IN CF AIRWAY EPITHELIUM downregulated in a number of malignancies (8, 12) and to act as profiling method using the Taqman MicroRNA Arrays v2.0 (released June a tumor suppressor in breast cancer (13). In silico analysis of a number 2009) from Applied Biosystems (Foster City, CA). of miRNA target prediction databases shows that TOM1 is a potential The content is derived from the miRBase (microRNA database) miRNA registry, providing comprehensive coverage of miRNAs from release 10.0, target of miR-126. TOM1 is a member of a family of proteins con- using the most up-to-date TaqMan MicroRNA Assays. Two array cards (A taining an N-terminal VHS (Vps27p/Hrs/STAM) domain reported to and B) for each sample were run on the Applied Biosystems 7900HT fast be involved in intracellular trafficking (14). Previous studies have real time PCR system, which measured expression levels of 667 different shown that TOM1 forms a complex with Toll-interacting protein human miRNAs in each sample and three positive and one negative control per card. RNA (30 ng) from clinical samples was reverse transcribed with (Tollip), a negative regulator of TLR2, TLR4, and IL-1RI signaling. the Megaplex primer pool (Applied Biosystems), allowing simultaneous This complex regulates endosomal trafficking of ubiquitinated pro- reverse transcription of 430 miRNAs and 36 endogenous controls in one teins (15). Moreover, this complex has been shown to traffic IL-1RI to RT pool (18). A preamplification step was performed on the Megaplex RT the endosome for degradation (16). TOM1 has also been proposed as product (5 ml) using TaqMan PreAmp Master Mix (23) and PreAmp 3 a negative regulator of IL-1b-andTNF-a–induced signaling path- Primer Mix (5 ; Applied Biosystems). The PreAmp primer pool con- tained forward primers specific for each miRNA and a universal reverse ways, whereby its overexpression can suppress the activity of the primer (Applied Biosystems). All miRNAs with cycle threshold (Ct) val- transcription factors NF-kB and AP-1 (17). In this study, we explore ues .35 were considered nonamplified or not expressed and were excluded the presence of miRNA in CF for the first time.
Recommended publications
  • Analysis of Gene Expression Data for Gene Ontology
    ANALYSIS OF GENE EXPRESSION DATA FOR GENE ONTOLOGY BASED PROTEIN FUNCTION PREDICTION A Thesis Presented to The Graduate Faculty of The University of Akron In Partial Fulfillment of the Requirements for the Degree Master of Science Robert Daniel Macholan May 2011 ANALYSIS OF GENE EXPRESSION DATA FOR GENE ONTOLOGY BASED PROTEIN FUNCTION PREDICTION Robert Daniel Macholan Thesis Approved: Accepted: _______________________________ _______________________________ Advisor Department Chair Dr. Zhong-Hui Duan Dr. Chien-Chung Chan _______________________________ _______________________________ Committee Member Dean of the College Dr. Chien-Chung Chan Dr. Chand K. Midha _______________________________ _______________________________ Committee Member Dean of the Graduate School Dr. Yingcai Xiao Dr. George R. Newkome _______________________________ Date ii ABSTRACT A tremendous increase in genomic data has encouraged biologists to turn to bioinformatics in order to assist in its interpretation and processing. One of the present challenges that need to be overcome in order to understand this data more completely is the development of a reliable method to accurately predict the function of a protein from its genomic information. This study focuses on developing an effective algorithm for protein function prediction. The algorithm is based on proteins that have similar expression patterns. The similarity of the expression data is determined using a novel measure, the slope matrix. The slope matrix introduces a normalized method for the comparison of expression levels throughout a proteome. The algorithm is tested using real microarray gene expression data. Their functions are characterized using gene ontology annotations. The results of the case study indicate the protein function prediction algorithm developed is comparable to the prediction algorithms that are based on the annotations of homologous proteins.
    [Show full text]
  • Association of Gene Ontology Categories with Decay Rate for Hepg2 Experiments These Tables Show Details for All Gene Ontology Categories
    Supplementary Table 1: Association of Gene Ontology Categories with Decay Rate for HepG2 Experiments These tables show details for all Gene Ontology categories. Inferences for manual classification scheme shown at the bottom. Those categories used in Figure 1A are highlighted in bold. Standard Deviations are shown in parentheses. P-values less than 1E-20 are indicated with a "0". Rate r (hour^-1) Half-life < 2hr. Decay % GO Number Category Name Probe Sets Group Non-Group Distribution p-value In-Group Non-Group Representation p-value GO:0006350 transcription 1523 0.221 (0.009) 0.127 (0.002) FASTER 0 13.1 (0.4) 4.5 (0.1) OVER 0 GO:0006351 transcription, DNA-dependent 1498 0.220 (0.009) 0.127 (0.002) FASTER 0 13.0 (0.4) 4.5 (0.1) OVER 0 GO:0006355 regulation of transcription, DNA-dependent 1163 0.230 (0.011) 0.128 (0.002) FASTER 5.00E-21 14.2 (0.5) 4.6 (0.1) OVER 0 GO:0006366 transcription from Pol II promoter 845 0.225 (0.012) 0.130 (0.002) FASTER 1.88E-14 13.0 (0.5) 4.8 (0.1) OVER 0 GO:0006139 nucleobase, nucleoside, nucleotide and nucleic acid metabolism3004 0.173 (0.006) 0.127 (0.002) FASTER 1.28E-12 8.4 (0.2) 4.5 (0.1) OVER 0 GO:0006357 regulation of transcription from Pol II promoter 487 0.231 (0.016) 0.132 (0.002) FASTER 6.05E-10 13.5 (0.6) 4.9 (0.1) OVER 0 GO:0008283 cell proliferation 625 0.189 (0.014) 0.132 (0.002) FASTER 1.95E-05 10.1 (0.6) 5.0 (0.1) OVER 1.50E-20 GO:0006513 monoubiquitination 36 0.305 (0.049) 0.134 (0.002) FASTER 2.69E-04 25.4 (4.4) 5.1 (0.1) OVER 2.04E-06 GO:0007050 cell cycle arrest 57 0.311 (0.054) 0.133 (0.002)
    [Show full text]
  • Aneuploidy: Using Genetic Instability to Preserve a Haploid Genome?
    Health Science Campus FINAL APPROVAL OF DISSERTATION Doctor of Philosophy in Biomedical Science (Cancer Biology) Aneuploidy: Using genetic instability to preserve a haploid genome? Submitted by: Ramona Ramdath In partial fulfillment of the requirements for the degree of Doctor of Philosophy in Biomedical Science Examination Committee Signature/Date Major Advisor: David Allison, M.D., Ph.D. Academic James Trempe, Ph.D. Advisory Committee: David Giovanucci, Ph.D. Randall Ruch, Ph.D. Ronald Mellgren, Ph.D. Senior Associate Dean College of Graduate Studies Michael S. Bisesi, Ph.D. Date of Defense: April 10, 2009 Aneuploidy: Using genetic instability to preserve a haploid genome? Ramona Ramdath University of Toledo, Health Science Campus 2009 Dedication I dedicate this dissertation to my grandfather who died of lung cancer two years ago, but who always instilled in us the value and importance of education. And to my mom and sister, both of whom have been pillars of support and stimulating conversations. To my sister, Rehanna, especially- I hope this inspires you to achieve all that you want to in life, academically and otherwise. ii Acknowledgements As we go through these academic journeys, there are so many along the way that make an impact not only on our work, but on our lives as well, and I would like to say a heartfelt thank you to all of those people: My Committee members- Dr. James Trempe, Dr. David Giovanucchi, Dr. Ronald Mellgren and Dr. Randall Ruch for their guidance, suggestions, support and confidence in me. My major advisor- Dr. David Allison, for his constructive criticism and positive reinforcement.
    [Show full text]
  • Supplementary Material and Methods
    Supplementary material and methods Generation of cultured human epidermal sheets Normal human epidermal keratinocytes were isolated from human breast skin. Keratinocytes were grown on a feeder layer of irradiated human fibroblasts pre-seeded at 4000 cells /cm² in keratinocyte culture medium (KCM) containing a mix of 3:1 DMEM and HAM’s F12 (Invitrogen, Carlsbad, USA), supplemented with 10% FCS, 10ng/ml epidermal growth factor (EGF; R&D systems, Minneapolis, MN, USA), 0.12 IU/ml insulin (Lilly, Saint- Cloud, France), 0.4 mg/ml hydrocortisone (UpJohn, St Quentin en Yvelelines, France) , 5 mg/ml triiodo-L- thyronine (Sigma, St Quentin Fallavier, France), 24.3 mg/ml adenine (Sigma), isoproterenol (Isuprel, Hospira France, Meudon, France) and antibiotics (20 mg/ml gentamicin (Phanpharma, Fougères, France), 100 IU/ml penicillin (Phanpharma), and 1 mg/ml amphotericin B (Phanpharma)). The medium was changed every two days. NHEK were then cultured over a period of 13 days according to the protocol currently used at the Bank of Tissues and Cells for the generation of clinical grade epidermal sheets used for the treatment of severe extended burns (Ref). When needed, cells were harvested with trypsin-EDTA 0.05% (Thermo Fisher Scientific, Waltham, MA, USA) and collected for analysis. Clonogenic assay Keratinocytes were seeded on a feeder layer of irradiated fibroblasts, at a clonal density of 10-20 cells/cm² and cultivated for 10 to 14 days. Three flasks per tested condition were fixed and colored in a single 30 mns step using rhodamine B (Sigma) diluted at 0.01 g/ml in 4% paraformaldehyde. In each tested condition, cells from 3 other flasks were numerated after detachment by trypsin treatment.
    [Show full text]
  • Mechanisms of Up-Regulation of Ubiquitin-Proteasome Activity in The
    bioRxiv preprint doi: https://doi.org/10.1101/2020.03.23.003053; this version posted March 23, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Mechanisms of up-regulation of Ubiquitin-Proteasome activity in the absence of NatA dependent N-terminal acetylation Ilia Kats1,2, Marc Kschonsak1,3, Anton Khmelinskii4, Laura Armbruster1,5, Thomas Ruppert1 and Michael Knop1,6,* 1 Zentrum für Molekulare Biologie der Universität Heidelberg (ZMBH), DKFZ-ZMBH Alliance, Im Neuenheimer Feld 282, 69120 Heidelberg, Germany. 2 present address: German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany 3 present address: Department of Structural Biology, Genentech Inc., South San Francisco, CA, USA. 4 Institute of Molecular Biology (IMB), Ackermannweg 4, 55128 Mainz, Germany. 5 present address: Centre for Organismal Studies (COS), Im Neuenheimer Feld 360, 69120 Heidelberg, Germany 6 Deutsches Krebsforschungszentrum (DKFZ), DKFZ-ZMBH Alliance, Im Neuenheimer Feld 280, 69120 Heidelberg, Germany. * corresponding author: [email protected] Abstract N-terminal acetylation is a prominent protein modification and inactivation of N-terminal acetyltransferases (NATs) cause protein homeostasis stress. Using multiplexed protein stability (MPS) profiling with linear ubiquitin fusions as reporters for the activity of the ubiquitin proteasome system (UPS) we observed increased UPS activity in NatA, but not NatB or NatC mutants. We find several mechanisms contributing to this behavior. First, NatA-mediated acetylation of the N-terminal ubiquitin independent degron regulates the abundance of Rpn4, the master regulator of the expression of proteasomal genes.
    [Show full text]
  • Population-Haplotype Models for Mapping and Tagging Structural Variation Using Whole Genome Sequencing
    Population-haplotype models for mapping and tagging structural variation using whole genome sequencing Eleni Loizidou Submitted in part fulfilment of the requirements for the degree of Doctor of Philosophy Section of Genomics of Common Disease Department of Medicine Imperial College London, 2018 1 Declaration of originality I hereby declare that the thesis submitted for a Doctor of Philosophy degree is based on my own work. Proper referencing is given to the organisations/cohorts I collaborated with during the project. 2 Copyright Declaration The copyright of this thesis rests with the author and is made available under a Creative Commons Attribution Non-Commercial No Derivatives licence. Researchers are free to copy, distribute or transmit the thesis on the condition that they attribute it, that they do not use it for commercial purposes and that they do not alter, transform or build upon it. For any reuse or redistribution, researchers must make clear to others the licence terms of this work 3 Abstract The scientific interest in copy number variation (CNV) is rapidly increasing, mainly due to the evidence of phenotypic effects and its contribution to disease susceptibility. Single nucleotide polymorphisms (SNPs) which are abundant in the human genome have been widely investigated in genome-wide association studies (GWAS). Despite the notable genomic effects both CNVs and SNPs have, the correlation between them has been relatively understudied. In the past decade, next generation sequencing (NGS) has been the leading high-throughput technology for investigating CNVs and offers mapping at a high-quality resolution. We created a map of NGS-defined CNVs tagged by SNPs using the 1000 Genomes Project phase 3 (1000G) sequencing data to examine patterns between the two types of variation in protein-coding genes.
    [Show full text]
  • Rabbit Anti-ZFYVE16/FITC Conjugated Antibody
    SunLong Biotech Co.,LTD Tel: 0086-571- 56623320 Fax:0086-571- 56623318 E-mail:[email protected] www.sunlongbiotech.com Rabbit Anti-ZFYVE16/FITC Conjugated antibody SL19157R-FITC Product Name: Anti-ZFYVE16/FITC Chinese Name: FITC标记的Zinc finger protein结构域ZFYVE16抗体 AI035632; B130024H06Rik; B130031L15; DKFZp686E13162; Endofin; Endosomal associated FYVE domain protein; Endosome associated FYVE domain protein; Endosome-associated FYVE domain protein; KIAA0305; KIAA0305;; mKIAA0305; Alias: OTTMUSP00000029589; RGD1564784; ZFY16_HUMAN; ZFYVE16; Zinc finger FYVE domain containing protein 16; Zinc finger FYVE domain-containing protein 16; Zinc finger, FYVE domain containing 16. Organism Species: Rabbit Clonality: Polyclonal React Species: Human,Mouse,Rat,Pig,Cow,Horse,Rabbit,Sheep, ICC=1:50-200IF=1:50-200 Applications: not yet tested in other applications. optimal dilutions/concentrations should be determined by the end user. Molecular weight: 88kDa Form: Lyophilized or Liquid Concentration: 1mg/ml immunogen: KLHwww.sunlongbiotech.com conjugated synthetic peptide derived from human ZFYVE16 Lsotype: IgG Purification: affinity purified by Protein A Storage Buffer: 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year Storage: when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C. background: This gene encodes an endosomal protein that belongs to the FYVE zinc finger family of Product Detail: proteins. The encoded protein is thought to regulate membrane trafficking in the endosome.
    [Show full text]
  • Protein Trafficking Or Cell Signaling: a Dilemma for the Adaptor Protein
    fcell-09-643769 February 22, 2021 Time: 19:20 # 1 REVIEW published: 26 February 2021 doi: 10.3389/fcell.2021.643769 Protein Trafficking or Cell Signaling: A Dilemma for the Adaptor Protein TOM1 Tiffany G. Roach1, Heljä K. M. Lång2,3, Wen Xiong1†, Samppa J. Ryhänen2 and Daniel G. S. Capelluto1* 1 Protein Signaling Domains Laboratory, Department of Biological Sciences, Fralin Life Sciences Institute, and Center for Soft Matter and Biological Physics, Virginia Tech, Blacksburg, VA, United States, 2 Division of Hematology, Oncology, and Stem Cell Transplantation, Children’s Hospital, and Pediatric Research Center, The New Children’s Hospital, University of Helsinki and Helsinki University Hospital, Helsinki, Finland, 3 Department of Anatomy and Stem Cells and Metabolism Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland Lysosomal degradation of ubiquitinated transmembrane protein receptors (cargo) relies on the function of Endosomal Sorting Complex Required for Transport (ESCRT) protein Edited by: Isabel Merida, complexes. The ESCRT machinery is comprised of five unique oligomeric complexes Consejo Superior de Investigaciones with distinct functions. Target of Myb1 (TOM1) is an ESCRT protein involved in the initial Científicas (CSIC), Spain steps of endosomal cargo sorting. To exert its function, TOM1 associates with ubiquitin Reviewed by: moieties on the cargo via its VHS and GAT domains. Several ESCRT proteins, including Brett Collins, University of Queensland, Australia TOLLIP, Endofin, and Hrs, have been reported to form a complex with TOM1 at early Caiji Gao, endosomal membrane surfaces, which may potentiate the role of TOM1 in cargo sorting. South China Normal University, China More recently, it was found that TOM1 is involved in other physiological processes, *Correspondence: Daniel G.
    [Show full text]
  • Rabbit Anti-TOM1/FITC Conjugated Antibody
    SunLong Biotech Co.,LTD Tel: 0086-571- 56623320 Fax:0086-571- 56623318 E-mail:[email protected] www.sunlongbiotech.com Rabbit Anti-TOM1/FITC Conjugated antibody SL17222R-FITC Product Name: Anti-TOM1/FITC Chinese Name: FITC标记的TOM1蛋白抗体 FLJ33404; OTTHUMP00000028777; Target of myb 1; TOM1_HUMAN; Target of Alias: Myb protein 1; Target of myb1; TOM 1. Organism Species: Rabbit Clonality: Polyclonal React Species: Human,Mouse,Rat,Dog,Pig,Cow,Horse,Sheep,Chimpanzee,Rhesus monkey ICC=1:50-200IF=1:50-200 Applications: not yet tested in other applications. optimal dilutions/concentrations should be determined by the end user. Molecular weight: 54kDa Form: Lyophilized or Liquid Concentration: 1mg/ml immunogen: KLH conjugated synthetic peptide derived from human TOM1 Lsotype: IgG Purification: affinity purified by Protein A Storage Buffer: 0.01Mwww.sunlongbiotech.com TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year Storage: when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C. background: This gene was identified as a target of the v-myb oncogene. The encoded protein shares its N-terminal domain in common with proteins associated with vesicular trafficking at the endosome. It is recruited to the endosomes by its interaction with endofin. Several Product Detail: alternatively spliced transcript variants encoding different isoforms have been found for this gene.
    [Show full text]
  • Ubiquitin-Binding Domains James H
    Biochem. J. (2006) 399, 361–372 (Printed in Great Britain) doi:10.1042/BJ20061138 361 REVIEW ARTICLE Ubiquitin-binding domains James H. HURLEY1, Sangho LEE and Gali PRAG Laboratory of Molecular Biology, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, U.S. Department of Health and Human Services, Bethesda, MD 20892, U.S.A. The covalent modification of proteins by ubiquitination is a major the activity of proteins that contain them. At least one of these regulatory mechanism of protein degradation and quality control, domains, the A20 ZnF, acts as a ubiquitin ligase by recruiting endocytosis, vesicular trafficking, cell-cycle control, stress res- a ubiquitin–ubiquitin-conjugating enzyme thiolester adduct in a ponse, DNA repair, growth-factor signalling, transcription, gene process that depends on the ubiquitin-binding activity of the A20 silencing and other areas of biology. A class of specific ubiquitin- ZnF. The affinities of the mono-ubiquitin-binding interactions of binding domains mediates most of the effects of protein ubiquit- these domains span a wide range, but are most commonly weak, ination. The known membership of this group has expanded with Kd>100 µM. The weak interactions between individual rapidly and now includes at least sixteen domains: UBA, UIM, domains and mono-ubiquitin are leveraged into physiologically MIU, DUIM, CUE, GAT, NZF, A20 ZnF, UBP ZnF, UBZ, Ubc, relevant high-affinity interactions via several mechanisms: ubi- UEV, UBM, GLUE, Jab1/MPN and PFU. The structures of many quitin polymerization, modification multiplicity, oligomerization of the complexes with mono-ubiquitin have been determined, of ubiquitinated proteins and binding domain proteins, tandem- revealing interactions with multiple surfaces on ubiquitin.
    [Show full text]
  • C5a Impairs Phagosomal Maturation in the Neutrophil Through Phosphoproteomic Remodeling
    C5a impairs phagosomal maturation in the neutrophil through phosphoproteomic remodeling Alexander J.T. Wood, … , Klaus Okkenhaug, Andrew Conway Morris JCI Insight. 2020;5(15):e137029. https://doi.org/10.1172/jci.insight.137029. Research Article Immunology Infectious disease Graphical abstract Find the latest version: https://jci.me/137029/pdf RESEARCH ARTICLE C5a impairs phagosomal maturation in the neutrophil through phosphoproteomic remodeling Alexander J.T. Wood,1 Arlette M. Vassallo,1 Marie-Hélène Ruchaud-Sparagano,2 Jonathan Scott,2 Carmelo Zinnato,1 Carmen Gonzalez-Tejedo,3 Kamal Kishore,3 Clive S. D’Santos,3 A. John Simpson,2,4 David K. Menon,1 Charlotte Summers,1 Edwin R. Chilvers,1,5 Klaus Okkenhaug,6 and Andrew Conway Morris1,6 1Department of Medicine, University of Cambridge, Addenbrooke’s Hospital, Hills Road, Cambridge, United Kingdom. 2Faculty of Medical Sciences, Newcastle University, Framlington Place, Newcastle upon Tyne, United Kingdom. 3Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge, United Kingdom. 4Newcastle upon Tyne Hospitals NHS Foundation Trust, Queen Victoria Road, Newcastle upon Tyne, United Kingdom. 5National Heart and Lung Institute, Imperial College, London, United Kingdom. 6Division of Immunology, Department of Pathology, University of Cambridge, Tennis Court Road, Cambridge, United Kingdom. Critical illness is accompanied by the release of large amounts of the anaphylotoxin, C5a. C5a suppresses antimicrobial functions of neutrophils which is associated with adverse outcomes. The signaling pathways that mediate C5a-induced neutrophil dysfunction are incompletely understood. Healthy donor neutrophils exposed to purified C5a demonstrated a prolonged defect (7 hours) in phagocytosis of Staphylococcus aureus. Phosphoproteomic profiling of 2712 phosphoproteins identified persistent C5a signaling and selective impairment of phagosomal protein phosphorylation on exposure to S.
    [Show full text]
  • Conserved Motifs and Prediction of Regulatory Modules in Caenorhabditis Elegans
    INVESTIGATION Conserved Motifs and Prediction of Regulatory Modules in Caenorhabditis elegans Guoyan Zhao,*,1 Nnamdi Ihuegbu,*,1 Mo Lee,† Larry Schriefer,* Ting Wang,* and Gary D. Stormo*,2 *Department of Genetics, Washington University School of Medicine, St. Louis, Missouri 63110, and †Brigham Young University, Provo, Utah 84602 ABSTRACT Transcriptional regulation, a primary mechanism for controlling the development of multicel- KEYWORDS lular organisms, is carried out by transcription factors (TFs) that recognize and bind to their cognate binding cis-regulatory sites. In Caenorhabditis elegans, our knowledge of which genes are regulated by which TFs, through element binding to specific sites, is still very limited. To expand our knowledge about the C. elegans regulatory cis-regulatory network, we performed a comprehensive analysis of the C. elegans, Caenorhabditis briggsae, and Caeno- module rhabditis remanei genomes to identify regulatory elements that are conserved in all genomes. Our analysis transcription identified 4959 elements that are significantly conserved across the genomes and that each occur multiple factor times within each genome, both hallmarks of functional regulatory sites. Our motifs show significant transcriptional matches to known core promoter elements, TF binding sites, splice sites, and poly-A signals as well as regulation many putative regulatory sites. Many of the motifs are significantly correlated with various types of exper- Caenorhabditis imental data, including gene expression patterns, tissue-specific expression patterns, and binding site elegans location analysis as well as enrichment in specific functional classes of genes. Many can also be significantly associated with specific TFs. Combinations of motif occurrences allow us to predict the location of cis- regulatory modules and we show that many of them significantly overlap experimentally determined enhancers.
    [Show full text]